These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17110708)
1. Doha Declaration has failed to deliver cheap drugs to developing countries, Oxfam says. O'Dowd A BMJ; 2006 Nov; 333(7577):1036. PubMed ID: 17110708 [No Abstract] [Full Text] [Related]
2. TRIPS, pharmaceuticals, developing countries, and the Doha "solution". Sykes AO Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299 [No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
4. [How are prices for important drugs stipulated in poor countries?]. Lien L Tidsskr Nor Laegeforen; 2003 Apr; 123(7):958-9. PubMed ID: 12737074 [No Abstract] [Full Text] [Related]
5. More drugs, less protection. Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521 [No Abstract] [Full Text] [Related]
6. Global health and university patents. Kapczynski A; Crone ET; Merson M Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943 [No Abstract] [Full Text] [Related]
7. New patent rules boost profits while safe drugs elude the world's poor, says Oxfam. Moszynski P BMJ; 2011 Feb; 342():d815. PubMed ID: 21300716 [No Abstract] [Full Text] [Related]
8. No deal in sight on cheap drugs for poor countries. Fleck F BMJ; 2003 Mar; 326(7387):465. PubMed ID: 12609924 [No Abstract] [Full Text] [Related]
9. New deal from the World Trade Organisation. Pollock AM; Price D BMJ; 2003 Sep; 327(7415):571-2. PubMed ID: 12969897 [No Abstract] [Full Text] [Related]
10. Huge inequalities in access to drugs partly because of intellectual property rights, says UN expert. Zarocostas J BMJ; 2009 Jun; 338():b2348. PubMed ID: 19515714 [No Abstract] [Full Text] [Related]
11. Patent immorality? Bloche MG; Jungman ER Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859 [No Abstract] [Full Text] [Related]
12. Some politics: against academic boycotts and for cheap drugs. BMJ; 2003 Jan; 326(7379):1 p. PubMed ID: 12705247 [No Abstract] [Full Text] [Related]
13. How poor countries can gain access to cheap drugs. Fleck F BMJ; 2003 Sep; 327(7416):642. PubMed ID: 14500433 [No Abstract] [Full Text] [Related]
14. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
15. World's poorest countries can improve access to medicines through local production, says United Nations. Zarocostas J BMJ; 2011 May; 342():d3101. PubMed ID: 21593099 [No Abstract] [Full Text] [Related]
16. Patents and access to drugs in developing countries: an ethical analysis. Sterckx S Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374 [TBL] [Abstract][Full Text] [Related]
17. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals. Correa CM Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300 [No Abstract] [Full Text] [Related]
18. Essential drugs for developing countries. Ceylon Med J; 1978; 23(2-3):41-4. PubMed ID: 263408 [No Abstract] [Full Text] [Related]
19. Better access to drugs in developing countries is accelerating resistance. Mayor S BMJ; 2010 Jun; 340():c3234. PubMed ID: 20558519 [No Abstract] [Full Text] [Related]